Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Rosenblatt
Jacalyn
J
Beth Israel Deaconess Medical Center, Boston, MA, USA.
Vasir
Baldev
B
Uhl
Lynne
L
Blotta
Simona
S
Macnamara
Claire
C
Somaiya
Poorvi
P
Wu
Zekui
Z
Joyce
Robin
R
Levine
James D
JD
Dombagoda
Dilani
D
Yuan
Yan Emily
YE
Francoeur
Karen
K
Fitzgerald
Donna
D
Richardson
Paul
P
Weller
Edie
E
Anderson
Kenneth
K
Kufe
Donald
D
Munshi
Nikhil
N
Avigan
David
D
D000328:Adult; D000368:Aged; D000913:Antibodies, Protozoan / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D002459:Cell Fusion; D003713:Dendritic Cells / Q000276:immunology*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy*
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D019496:Cancer Vaccines